NLS Pharmaceutics Ltd

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
NLS Pharmaceutics Ltd
TickerNLSPW
CIK #0001783036
CUSIPH57830111
SectorLife Sciences - Pharmaceutical Preparations
AddressAlter Postplatz 2, Stans, CH-6370
Source [EDGAR]
CIK Filing 2011 - 2025
[0001783036] 6-K
[0001783036] D
[0001783036] SC 13D
[0001783036] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Hafner Ronald NLS Pharmaceutics Ltd [2025-06-24] 0.0
Armistice Capital LLC NLS Pharmaceutics Ltd [2024-11-14] 0.99
Alpha Capital Anstalt NLS Pharmaceutics Ltd [2024-10-15] 9.99
Lind Global Fund II LP NLS Pharmaceutics Ltd [2024-03-27] 9.9
Grisard Felix NLS Pharmaceutics Ltd [2023-02-24] 0.99
Biotechnology Value Fund L P NLS Pharmaceutics Ltd [2022-12-16] 12.1
Konofal Eric NLS Pharmaceutics Ltd [2022-02-24] 6.3
Magnetic Rock Investment AG NLS Pharmaceutics Ltd [2022-02-18] 20.0
Zwyer Alexander NLS Pharmaceutics Ltd [2022-02-14] 7.4
Ya II PN Ltd NLS Pharmaceutics Ltd [2021-10-08] 0.0
Hirschman Orin NLS Pharmaceutics Ltd [2021-02-04] 7.8
Form 13F Holdings
Firm Period DFND Voting Shares
Clear Street LLC [2025-06-30] SOLE 57,762 57,762
Susquehanna International Group LLP [2025-06-30] OTR 16,333 16,333
Armistice Capital LLC [2025-06-30] SOLE 12,500 12,500
Concourse Financial Group Securities Inc [2025-06-30] SOLE 0 0
Prev | Page 12 | Next
Terms | Privacy | Guide
tony@aum13f.com